(2R,3S,11bS)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol (ACI)

N-Ethyl-N′-[2-methoxy-4-[5-methyl-4-[[(1S)-1-(3-pyridinyl)butyl]amino]-2-pyrimidinyl]phenyl]urea (ACI)

6,7-Dimethoxy-4-[(3R)-3-(2-quinoxalinyloxy)-1-pyrrolidinyl]quinazoline (ACI)

(+)-Kobusin

(-)-Licarin A

8-[2-O-[(2E)-3-(4-Hydroxyphenyl)-1-oxo-2-propen-1-yl]-β-D-glucopyranosyl]-2-[(2R)-2-hydroxypropyl]-7-methoxy-5-methyl-4H-1-benzopyran-4-one (ACI)

(2E)-3-(3,4-Dimethoxyphenyl)-N-2-thiazolyl-2-propenamide (ACI)

Enlimomab

L-Histidyl-L-seryl-L-α-aspartylglycyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-α-aspartyl-L-seryl-L-tyrosyl-L-seryl-L-arginyl-L-tyrosyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-alanyl-L-valyl-L-leucylglycyl-L-lysyl-L-arginyl-L-tyrosyl-L-lysyl-L-glutaminyl-L-arginyl-L-valyl-L-lysyl-L-asparaginyl-L-lysine (ACI)

Immunoglobulin G1, anti-(human plasma kallikrein) (human monoclonal DX-2930 heavy chain), disulfide with human monoclonal DX-2930 light chain, dimer (ACI)

Sorbitan monododecanoate (ACI)

Rifalazil

MEDI 575

Ligelizumab

Radretumab

Immunoglobulin G4, anti-(human NKG2A/CD94 receptor) (human-mouse monoclonal humZ270 heavy chain), disulfide with human-mouse monoclonal humZ270 light chain, dimer (ACI)

Glembatumumab vedotin

Secukinumab

Blosozumab

Oxelumab